Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Employers are balancing cost control with strategic investments in skills, paying high performers, pay equity and total rewards
Semaglutide is a GLP-1 receptor agonist found in three FDA-approved medications by Novo Nordisk: Ozempic : an injectable used to lower blood sugar and reduce cardiovascular risk in adults with type 2 diabetes
Who Should Not Use GLP-1
That assumption can be dangerous
GLP-1 Weight Loss Program Provider-prescribed semaglutide or tirzepatide as low as $194/mo* Full-dose GLP-1 therapy with ongoing provider support designed for meaningful, sustainable weight loss
US$ 28.78
US$ 29.79
US$ 21.47
US$ 24.22
US$ 28.63
US$ 22.93
US$ 24.03
